Hikma operates globally through a network of 58 subsidiaries, all of which are ultimately owned or controlled by Hikma Pharmaceuticals PLC, a publicly traded company headquartered in London, United Kingdom. Our main operations are spread across 11 countries in various geographical regions, with key ...